Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
BioCryst Pharmaceuticals
AddedFeb 19, 2024
UpdatedJun 18, 2026
BioCryst Pharmaceuticals

BioCryst Pharmaceuticals

Public

BioCryst Pharmaceuticals: A global biotech firm innovating oral treatments for rare diseases.

HQ
Durham, NC, US
Founded
1986
Overview
Compare
Fundraising
Employees
Website

BioCryst Pharmaceuticals, founded in 1986, is a global biotech firm dedicated to discovering and developing novel, oral, small-molecule medicines for rare diseases where significant unmet medical needs exist. The company focuses on conditions where an enzyme plays a crucial role in the disease's biological pathway. BioCryst aims to restore a sense of freedom for patients with complement-mediated and other rare diseases through its innovative treatments. With over three decades of experience, BioCryst serves clients worldwide.

Notable affiliated individuals include key researchers and executives who have driven the company's mission forward. BioCryst has attracted significant investment from leading biotech investors, which has fueled its research and development initiatives. Key achievements include the successful development and commercialization of several groundbreaking therapies that have significantly impacted patients' lives. BioCryst's commitment to innovation and patient care has established it as a leader in the biotech industry, making substantial contributions to the treatment of rare diseases globally.

BioCryst Pharmaceuticals - Similar Companies

PTC Therapeutics logo

PTC Therapeutics

ptcbio.com

Catalyst Pharmaceuticals logo

Catalyst Pharmaceuticals

catalystpharma.com

Krystal Biotech logo

Krystal Biotech

krystalbio.com

BioMarin logo

BioMarin

biomarin.com

Brii Biosciences logo

Brii Biosciences

briibio.com

Lumos Pharma logo

Lumos Pharma

lumos-pharma.com

Attune Pharmaceuticals logo

Attune Pharmaceuticals

Bayer Pharmaceuticals logo

Bayer Pharmaceuticals

bayer.com

Astria Therapeutics logo

Astria Therapeutics

astriatx.com

Harmony Biosciences logo

Harmony Biosciences

X4 Pharmaceuticals logo

X4 Pharmaceuticals

x4pharma.com

Bond Biosciences logo

Bond Biosciences

bond.bio

Amicus Therapeutics logo

Amicus Therapeutics

amicusrx.com

Biomarck Pharmaceuticals logo

Biomarck Pharmaceuticals

BridgeBio Pharma logo

BridgeBio Pharma

bridgebio.com

BioCryst Pharmaceuticals - Quick Facts

Who are BioCryst Pharmaceuticals' competitors?

Companies similar to BioCryst Pharmaceuticals include PTC Therapeutics, Catalyst Pharmaceuticals, Krystal Biotech and BioMarin.

When was BioCryst Pharmaceuticals founded?

BioCryst Pharmaceuticals was founded in 1986.

Where is BioCryst Pharmaceuticals' headquarters located?

BioCryst Pharmaceuticals' headquarters is located in Durham, NC, US.

When was BioCryst Pharmaceuticals' last funding round?

BioCryst Pharmaceuticals' most recent funding round was for $450M (USD) in April 2023.

How much has BioCryst Pharmaceuticals raised to-date?

As of Apr 17, 2023, BioCryst Pharmaceuticals has raised a total of $1.8B (USD).

How many employees does BioCryst Pharmaceuticals have?

BioCryst Pharmaceuticals has 531 employees as of Feb 6, 2024.

BioCryst Pharmaceuticals - Classification

Ownership
  • Public
Technology
  • Biotech
Geographic Exposure
  • Global
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Pharmaceuticals
Tags
  • Biotech
Unique IDs
  • ein: 621413174
  • secCik: 0000882796
  • ticker: BCRX
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 2836Biological Products, Except Diagnostic Substances
  • 2800Chemicals And Allied Products
  • 2830Drugs
ISIC
  • 2100Manufacture of pharmaceuticals, medicinal chemical and botanical products
Show 24 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325414Biological Product (except Diagnostic) Manufacturing
  • 424000Merchant Wholesalers, Nondurable Goods
  • 424200Drugs and Druggists' Sundries Merchant Wholesalers
  • 424210Drugs and Druggists' Sundries Merchant Wholesalers
  • 420000Wholesale Trade
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 5100Wholesale trade--nondurable goods
  • 5120Drugs, Drug Proprietaries, And Druggists' Sundries
  • 5122Drugs, Drug Proprietaries, and Druggists' Sundries
  • 4000Railroad Transportation
  • 8000Health Services
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8730Research, Development, And Testing Services
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
  • 8731Commercial Physical and Biological Research
ISIC
  • 4649Wholesale of other household goods